Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

86
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
86
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

81
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Nephrons01:10

Nephrons

3.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.4K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

71
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
71

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Planning of kidney replacement therapy in advanced CKD using the KFRE formula in a Spanish multicenter cohort.

Clinical kidney journal·2026
Same author

Trial End Points in ANCA-Associated Vasculitis: Are We Missing the Boat?

Journal of the American Society of Nephrology : JASN·2026
Same author

Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports.

Clinical kidney journal·2026
Same author

Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

RMD open·2026
Same author

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Uromodulin and Tryptophan Metabolite Clearance in Hemodialyzed Patients.

Journal of clinical medicine·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833

El COVID largo y el riñón

Vanja Ivković1, Urmila Anandh2, Samira Bell3

  • 1Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. vanja.ivkovic@gmail.com.

Nature reviews. Nephrology
|September 4, 2025
PubMed
Resumen

El COVID prolongado, una condición persistente después de la infección por SARS-CoV-2, puede conducir a una enfermedad renal crónica (ERC). La vacunación contra el SARS-CoV-2 es crucial para prevenir el COVID-19 grave y el COVID prolongado, especialmente en pacientes con ERC.

Más Videos Relacionados

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

770
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

278

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833
Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

770
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

278

Área de la Ciencia:

  • Nefrología
  • Enfermedades infecciosas
  • Salud pública

Sus antecedentes:

  • La enfermedad por coronavirus prolongada (COVID) es una condición compleja que afecta a múltiples sistemas de órganos, incluidos los riñones, que persiste durante más de tres meses después de la infección por SARS-CoV-2.
  • El COVID-19 está relacionado con la lesión renal aguda y un mayor riesgo de enfermedad renal crónica (ERC), lo que sugiere que la ERC es una manifestación potencial del COVID prolongado.
  • Los pacientes con ERC preexistente enfrentan un mayor riesgo de COVID-19 grave y de desarrollar COVID prolongado.

Objetivo del estudio:

  • Explorar el impacto multifacético del COVID-19 en la salud renal, incluido el desarrollo y la progresión de la enfermedad renal crónica.
  • Para resaltar la relación bidireccional entre COVID-19, COVID largo y enfermedad renal crónica.
  • Hacer hincapié en el papel de la vacunación contra el SARS-CoV-2 en la mitigación de los riesgos asociados con el COVID-19 y el COVID prolongado, especialmente para las poblaciones de ERC vulnerables.

Principales métodos:

  • Revisión de la literatura y los estudios existentes que investigan las manifestaciones renales del COVID-19 y el COVID largo.
  • Análisis de las asociaciones reportadas entre la infección por SARS-CoV-2 y las enfermedades renales, incluida la nefropatía y la vasculitis asociadas a COVID-19.
  • Evaluación del impacto de la vacunación contra el SARS-CoV-2 en el COVID-19 y la incidencia de COVID prolongado en la población general y los pacientes con ERC.

Principales resultados:

  • El COVID-19 puede causar lesión renal aguda y se asocia con un mayor riesgo de desarrollar enfermedad renal crónica (ERC).
  • Se han relacionado enfermedades renales específicas como la glomerulopatía colapsante y la vasculitis de nueva aparición con el COVID-19.
  • La vacunación contra el SARS-CoV-2 reduce significativamente el riesgo de COVID-19 y COVID prolongado, ofreciendo protección a todas las personas, especialmente a las que tienen ERC.

Conclusiones:

  • La enfermedad renal crónica (ERC) puede ser una secuela significativa del COVID prolongado, lo que requiere investigación y monitoreo continuos.
  • La interacción entre el COVID-19 y la ERC subraya la importancia de la atención integral para los pacientes afectados.
  • El seguimiento estructurado para los sobrevivientes de COVID-19 es esencial para comprender las trayectorias largas de COVID e identificar a las personas en riesgo de ERC.